Canaccord Genuity Reiterates a 'Buy' on OraSure Technologies (OSUR); OraQuick HIV-OTC Test in 30,000 Locations
Tweet Send to a FriendGet Alerts OSUR Hot Sheet
Price: $4.32 -0.69%
Rating Summary:
11 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 24 | New: 29
Rating Summary:
11 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 24 | New: 29
Trade OSUR Now!
Canaccord Genuity reiterates a 'Buy' on OraSure Technologies (NASDAQ: OSUR) price target of $14.00.
Analyst, Jeffrey Frelick, said, "Reiterate our rating following FDA approval of the OraQuick HIV-OTC test, the first rapid OTC test approved for HIV...OSUR expects to sell into 20-25 different retailers across 30,000 locations, including Walgreens (NYSE: WAG), CVS (NYSE: CVS), Wal-Mart (NYSE: WMT), Rite Aid (NYSE: RAD) and Kroger (NYSE: KR), and expects to reach a large percentage of its audience through retail store circulars. One retailer agreed to include a sign at the pharmacy to market the test...We expect OSUR will record $7.0M in sales in 2013 assuming an ASP of $35 and modest 0.4% penetration rate."
For an analyst ratings summary and ratings history on OraSure Technologies click here. For more ratings news on OraSure Technologies click here.
Shares of OraSure Technologies closed at $13.36 yesterday, with a 52 week range of $6.29-$13.65.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Jeffrey Frelick, said, "Reiterate our rating following FDA approval of the OraQuick HIV-OTC test, the first rapid OTC test approved for HIV...OSUR expects to sell into 20-25 different retailers across 30,000 locations, including Walgreens (NYSE: WAG), CVS (NYSE: CVS), Wal-Mart (NYSE: WMT), Rite Aid (NYSE: RAD) and Kroger (NYSE: KR), and expects to reach a large percentage of its audience through retail store circulars. One retailer agreed to include a sign at the pharmacy to market the test...We expect OSUR will record $7.0M in sales in 2013 assuming an ASP of $35 and modest 0.4% penetration rate."
For an analyst ratings summary and ratings history on OraSure Technologies click here. For more ratings news on OraSure Technologies click here.
Shares of OraSure Technologies closed at $13.36 yesterday, with a 52 week range of $6.29-$13.65.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Analyst Sees Potential for Omeros' (OMER) OMS824 as FDA Gives Clearance
- Canaccord Boosts PT on AcelRx (ACRX) to $11; On Track for Sufentanil NDA Submission by Q313
- Benchmark Boosts PT on R.R. Donnelley (RRD)
Create E-mail Alert Related Categories
Analyst Comments, FDARelated Entities
Canaccord Genuity
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
